Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii
In conclusion, our findings indicate that melittin possesses considerable potential for use in combination with colistin and imipenem to treat infections caused by MDR strong biofilm producerA. baumannii isolates.
Source: European Journal of Clinical Microbiology and Infectious Diseases - Category: Microbiology Source Type: research
More News: Acinetobacter | Cipro | Ciprofloxacin | Infectious Diseases | Microbiology | Multidrug Resistance | PET Scan | Statistics | Study